D. Sawada

Core Technology Laboratories, Asahi Quality and Innovations, Ltd., 11-10, 5 Chome, Fuchinobe, Chuo-ku, Sagamihara-shi, Kanagawa 252-0206, Japan

Health Outcomes Studied

• Improved Bowel Movement Frequency
• Improved Gut Microbiota
• Improved Insulin Levels
• Improved Insulin Sensitivity
• Reduced Diastolic Blood Pressure
• Reduced Low-Density Lipoprotein Level
• Reduced Total Cholesterol Levels
• Reduced Uric Acid Levels
• Reduced Visceral Fat

Papers (7)

• 2020
  Daily Intake of Paraprobiotic Lactobacillus amylovorus CP1563 Improves Pre-Obese Conditions and Affects the Gut Microbial Community in Healthy Pre-Obese Subjects: A Double-Blind, Randomized, Placebo-Controlled Study10.3390/microorganisms8020304
• 2019
  Health Benefits of Lactobacillus gasseri CP2305 Tablets in Young Adults Exposed to Chronic Stress: A Randomized, Double-Blind, Placebo-Controlled Study10.3390/nu11081859
• 2016
  Regulatory effect of paraprobiotic Lactobacillus gasseri CP2305 on gut environment and function10.3402/mehd.v27.30259
• 2016
  Effect of fragmented Lactobacillus amylovorus CP1563 on lipid metabolism in overweight and mildly obese individuals: a randomized controlled trial10.3402/mehd.v27.30312
• 2010
  Effects of Oral Administration of Lactobacillus acidophilus L-92 on the Symptoms and Serum Markers of Atopic Dermatitis in Children10.1159/000321110
• 2005
  Effect of Milk Fermented with Lactobacillus acidophilus Strain L-92 on Symptoms of Japanese Cedar Pollen Allergy: A Randomized Placebo-Controlled Trial10.1271/bbb.69.1652
• 2005
  Clinical effects of Lactobacillus acidophilus strain L-92 on perennial allergic rhinitis: a double-blind, placebo-controlled study.10.3168/JDS.S0022-0302(05)72714-4